Trademark: 77767425
Status Date
Friday, April 5, 2019
Registration Number
4200422
Registration Date
Tuesday, September 4, 2012
Filing Date
Wednesday, June 24, 2009
Published for Opposition
Tuesday, November 29, 2011
Cancellation Date
Friday, April 5, 2019
1 Enzymes for scientific and research purposes in connection with treatment of the eye; chemicals for use in industry and science, namely, chemicals for in-vitro use and analysis in laboratories in connection with treatment for the eye; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, nucleic acid sequences and chemical reagents for other than medical and veterinary purposes, namely, cloning vehicles and vectors and recombinant deoxyribonucleic acid variations thereof, all for in-vitro and in-vivo use in laboratory or medical research in connection with treatment for the eye; chemical reagents for use in medical science
5 Gene therapy products, namely, genetically engineered tissues for transplant purposes and gene delivery pharmaceuticals; vaccines, enzymes and enzyme preparations, anti-apoptopic and angiostatic / angiogenic molecules, all for medical purposes in connection with the treatment of diseases of the eye; nucleic acid sequences and chemical reagents for medical purposes in connection with the treatment of diseases of the eye, namely, retroviral vectors and retroviral vector manufacturing preparations; pharmaceutical and biochemical preparations for the treatment of diseases of the eye and Usher's disease; biochemical preparations for medical purposes, namely, gene based therapeutics for the treatment of a juvenile degenerative retinal disease; pre-filled vials containing gene therapy pharmaceutical preparations in connection with the treatment of diseases of the eye
10 Medical instruments and apparatus for the administration of antibody-based therapy, gene therapy and prophylaxis preparations and substances in connection with the treatment of diseases of the eye; syringes and injectors for medical purposes in connection with the treatment of diseases of the eye
42 Scientific and medical research and development in connection with the treatment of diseases of the eye; genetic engineering services, biotechnology services, namely, research and development of new products for others in the field of biotechnology in connection with the treatment of diseases of the eye; advisory services relating to research and development of gene therapy products all in connection with the treatment of diseases of the eye and specifically excluding analysis services
In the statement, Page 2, Column 1, line 12,"12-9-2009" should be deleted, and 12-3-2009 should be inserted.
Color is not claimed as a feature of the mark.
ENCORE STAT
Apr 5, 2019
Cancelled Sec. 8 (6-Yr)
Jun 8, 2018
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 8, 2018
Teas Change Of Owner Address Received
Sep 4, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Mar 14, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 14, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 26, 2012
Certificate Of Correction Issued
Sep 22, 2012
Case Assigned To Post Registration Paralegal
Sep 17, 2012
Teas Section 7 Request Received
Sep 4, 2012
Registered-Principal Register
Jul 31, 2012
1(B) Basis Deleted; Proceed To Registration
Jul 20, 2012
Notice Of Allowance Cancelled
Jul 20, 2012
Teas Delete 1(B) Basis Received
Feb 22, 2012
Corrected Noa E-Mailed
Feb 21, 2012
Notice Of Allowance Correction Entered
Feb 16, 2012
Case Assigned To Intent To Use Paralegal
Jan 25, 2012
Fax Received
Jan 24, 2012
Noa E-Mailed - Sou Required From Applicant
Nov 29, 2011
Official Gazette Publication Confirmation E-Mailed
Nov 29, 2011
Published For Opposition
Nov 9, 2011
Notification Of Notice Of Publication E-Mailed
Oct 21, 2011
Law Office Publication Review Completed
Oct 19, 2011
Approved For Pub - Principal Register
Oct 18, 2011
Teas/Email Correspondence Entered
Oct 18, 2011
Correspondence Received In Law Office
Oct 11, 2011
Teas Response To Office Action Received
May 18, 2011
Notification Of Non-Final Action E-Mailed
May 18, 2011
Non-Final Action E-Mailed
May 18, 2011
Non-Final Action Written
Apr 29, 2011
Lie Checked Susp - To Atty For Action
Oct 22, 2010
Report Completed Suspension Check Case Still Suspended
Oct 7, 2010
Assigned To Lie
Apr 7, 2010
Notification Of Letter Of Suspension E-Mailed
Apr 7, 2010
Letter Of Suspension E-Mailed
Apr 7, 2010
Suspension Letter Written
Mar 18, 2010
Teas/Email Correspondence Entered
Mar 17, 2010
Correspondence Received In Law Office
Mar 17, 2010
Teas Response To Office Action Received
Sep 23, 2009
Notification Of Non-Final Action E-Mailed
Sep 23, 2009
Non-Final Action E-Mailed
Sep 23, 2009
Non-Final Action Written
Sep 22, 2009
Assigned To Examiner
Jun 30, 2009
Notice Of Pseudo Mark Mailed
Jun 29, 2009
New Application Office Supplied Data Entered In Tram
Jun 27, 2009
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
